Deadline: Wednesday, July 17, 2019, noon
The Pfizer-NCBiotech Distinguished Postdoctoral Fellowship in Gene Therapy is a unique partnership between Pfizer Inc. and the North Carolina Biotechnology Center that supports the scientific and professional development of exceptional postdoctoral fellows interested in establishing research careers in gene therapy. Competitive awards fund two-year fellowships that enable early career scientists to conduct research in the laboratories of gene therapy-related investigators at any North Carolina university.
Eligible research projects will propose to:
- Develop adeno-associated virus (AAV)-based gene therapy platforms or address challenges (e.g., immunogenicity) associated with the use of these platforms; and/or
- Develop AAV gene therapy-enabling technologies/methodologies, such as gene editing, vector delivery, or gene therapy product manufacturing; and/or
- Explore novel applications of AAV-based gene therapies, such as target validation and preliminary testing of AAV constructs in models of disease.
Pfizer-NCBiotech fellowships feature professional development training in non-technical areas such as leadership and communication skills, FDA regulations related to biological therapies, project management skills, scalable manufacturing of gene therapy products, intellectual property and entrepreneurship.
Applications are submitted by qualifying researchers with faculty appointments at any North Carolina university and must name a specific Fellow candidate.
Application guidelines and instructions can be found here.
Questions? Want to request a consultation? Contact Deborah De at email@example.com.